Entry Point Capital, LLC Insmed Inc Put Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INSM
# of Institutions
447Shares Held
170MCall Options Held
5.79MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA16MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$864 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$417 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$331 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.62B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...